iShares IV - iShares NASDAQ US Biotechnology UCITS ETF (BMV:BTEC1 N) - Stock Price, News & Analysis

BTEC1 N Stock Overview

An exchange traded fund launched by BlackRock Asset Management Ireland Limited.

BTEC1 N fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Competitors

Price History & Performance

Summary of all time highs, changes and price drops for iShares IV - iShares NASDAQ US Biotechnology UCITS ETF
Historical stock prices
Current Share Price	US$132.60
52 Week High	US$138.31
52 Week Low	US$94.91
Beta	0
11 Month Change	-4.13%
3 Month Change	14.11%
1 Year Change	30.33%
33 Year Change	-13.27%
5 Year Change	45.35%
Change since IPO	45.79%

Recent updates

Shareholder Returns

	BTEC1 N	MX Capital Markets	MX Market
7D	0.7%	0.4%	0.8%
1Y	30.3%	-1.3%	3.9%

Return vs Industry: BTEC1 N exceeded the MX Capital Markets industry which returned 1.9% over the past year.

Return vs Market: BTEC1 N exceeded the MX Market which returned 3.7% over the past year.

Price Volatility

Is BTEC1 N's price volatile compared to industry and market?
BTEC1 N volatility
BTEC1 N Average Weekly Movement	n/a
Capital Markets Industry Average Movement	3.5%
Market Average Movement	4.1%
10% most volatile stocks in MX Market	5.9%
10% least volatile stocks in MX Market	2.7%

Stable Share Price: BTEC1 N has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BTEC1 N's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	n/a	n/a	www.ishares.com/uk/individual/en/products/291450/

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States.

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Fundamentals Summary

How do iShares IV - iShares NASDAQ US Biotechnology UCITS ETF's earnings and revenue compare to its market cap?
BTEC1 N fundamental statistics
Market cap	Mex$10.34b
Earnings (TTM)	Mex$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is BTEC1 N overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BTEC1 N income statement (TTM)
Revenue	Mex$0
Cost of Revenue	Mex$0
Gross Profit	Mex$0
Other Expenses	Mex$0
Earnings	Mex$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did BTEC1 N perform over the long term?

See historical performance and comparison

iShares IV - iShares NASDAQ US Biotechnology UCITS ETF BMV:BTEC1 N Stock Report